Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Neurological manifestations of Behçet's disease.]
Transcription factors and th17 cell development in experimental autoimmune encephalomyelitis.
Auditory evoked potentials and vestibular evoked myogenic potentials in evaluation of brainstem lesions in multiple sclerosis.
Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway.
Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.
A review on ROCK-II inhibitors: From molecular modelling to synthesis.
[Symptoms and clinical manifestations in neuromyelitis optica].
Month of birth and the incidence of multiple sclerosis in southern iran.
Evaluation of diffusion kurtosis imaging in ex vivo hypomyelinated mouse brains.
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.
Orthopaedic Management of Spasticity.
Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist.
[Assessment of the effectiveness and safety of Sativex ® in compassionate use].
[Oculomotor system and multiple sclerosis.]
[Oral treatments in multiple sclerosis].
A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells.
Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.
Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine.
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series.
Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels.
[The specialised MS networks, at the heart of the organisation of patient paths].
Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients.
Management of multiple sclerosis.
Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury.
Optic nerve head component responses of the multifocal electroretinogram in MS.
Pages
« first
‹ previous
…
522
523
524
525
526
527
528
529
530
…
next ›
last »